Kulicke & Soffa (KLIC) Q1 2026 earnings review
V-Shaped Recovery Confirmed; Guidance Signals Acceleration
Kulicke & Soffa delivered a definitive signal that the cyclical trough is behind it. Q1 revenue of $199.6M beat the recovery trajectory, up 12% sequentially, driven by >80% utilization rates in General Semiconductor and Memory. The standout metric is the Q2 revenue guidance of $230M, implying a 15% sequential acceleration and 42% YoY growth. While Operating Cash Flow turned negative due to aggressive working capital builds (Receivables/Inventory) to support this ramp, the expansion in Gross Margin to 49.6% indicates strong operating leverage is returning.
🐂 Bull Case
Gross margins expanded ~400bps sequentially to 49.6% as volume returned. With Q2 revenue guided up another 15%, the company is entering the 'sweet spot' of its operating model where incremental revenue flows efficiently to the bottom line.
The ramp is not just cyclical; it's structural. Management cited 'higher near-term capacity requirements' driven by technology transitions in Fluxless Thermo-Compression (FTC) and Advanced Dispense, validating their R&D investments during the downturn.
🐻 Bear Case
Operating Cash Flow swung to negative $(8.9)M from +$31.6M last quarter. The company consumed ~$48M in working capital (Inventory + AR) to fund growth. While typical for a ramp, this cash consumption bears watching if collections lag.
With Lester Wong still serving as Interim CEO following the sudden retirement of Fusen Chen in Q4, the company lacks permanent leadership during a critical execution phase for its HBM and Advanced Packaging strategy.
⚖️ Verdict: 🟢🟢
Strong Bullish. The guidance for $230M revenue in Q2 is a decisive breakout from the ~$170M stagnation range. Profitability is ramping faster than revenue due to margin expansion, validating the cyclical recovery thesis.
Key Themes
Core Market Utilization >80%
The primary engine for the beat and raise is the normalization of the core General Semiconductor and Memory markets. Utilization rates have crossed the critical 80% threshold (with China near 90% in prior commentary), triggering the release of pent-up capacity buys that were deferred throughout FY25.
Working Capital Drag on Cash
The rapid revenue ramp has temporarily inverted the cash flow profile. Accounts Receivable surged by $32M (+17.5% QoQ) and Inventory by $16M (+10% QoQ) in a single quarter. This working capital build resulted in negative Operating Cash Flow of $(8.9)M, a sharp reversal from positive generation in FY25.
Advanced Packaging & HBM Entry
The narrative is shifting from 'preparation' to 'execution.' Investments in Fluxless Thermo-Compression (FTC) and Vertical Wire are now contributing to the outlook. The guidance implies these new product lines are layering on top of the cyclical recovery, supporting the margin expansion to nearly 50%.
Capital Return Deceleration
Share repurchases slowed significantly to $6.7M (0.2M shares) in Q1, down from $16.7M in Q4 and ~$21M in Q2/Q3. With the stock likely rising and cash being diverted to working capital for the ramp, the buyback tailwind may mute temporarily.
Other KPIs
Accelerating. Up from 45.7% in Q4 and 46.7% in Q3. This near-50% level was previously a medium-term target; achieving it in the first quarter of the recovery cycle indicates strong pricing power or mix benefits from advanced tools.
Accelerating. Up 57% sequentially from $0.28 in Q4. It significantly outpaced revenue growth (+12% seq), demonstrating powerful operating leverage.
Stable. Down slightly from $510.7M in Q4 due to negative operating cash flow and buybacks. The balance sheet remains a fortress with ~$9.20 per share in net cash.
Guidance
Accelerating. Represents a +15% sequential jump and +42% YoY growth vs the depressed 25Q2 ($162M). This magnitude of sequential growth confirms a V-shaped recovery is underway.
Accelerating. Implies +52% sequential growth vs Q1 ($0.44). The guidance suggests margins will hold or expand further as volume increases.
Key Questions
Working Capital Normalization
Operating Cash Flow turned negative due to a sharp rise in receivables and inventory. When do you expect collections to catch up, and what are the working capital requirements to support a $230M+ revenue run rate?
HBM Qualification Milestones
With the HBM market ramping aggressively, can you provide specific milestones for the Fluxless Thermo-Compression qualification with your memory partner? Is revenue contribution baked into the FY26 outlook?
Gross Margin Sustainability
Gross margins hit 49.6% ahead of schedule. Is this driven by product mix (Advanced Packaging) or simply higher volume overhead absorption? Can we expect 50%+ margins in Q2?